STAN311i-906C1
** The karyotype for this cell line may contain a non-clonal finding known to be recurrent in pluripotent stem cells. Please see the karyotype report in the currently distributing lot(s) “Product Information & Testing” PDF(s) linked below for more information.An additional clone from this iPS cell line (STAN312i-906C3) is available from WiCell.
Cell Line Alias | ISMMS 906i C1 |
Cell Type | Human iPS |
Disease | None reported |
Sex | Male |
Age at Collection | 61 Years |
Ethnicity | Caucasian |
Ethnicity Information | Self-reported |
Genetically Related Cell Lines | |
Reprogramming Method | Sendai Virus (Oct4, Klf4, Sox2, Myc) |
Tissue Origin | Blood |
Provider | Stanford University - Dr. Thomas Quertermous |
dbGaP Data | |
hPSCReg ID | |
NIH Approval | |
Pub Med Abstract | |
Collection(s) | NHLBI Next Gen - Insulin resistance syndrome (Dr. Thomas Quertermous, Stanford University) |
Current Lot Information
Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
---|---|---|---|---|---|---|
DB44418 | mTeSR1/Matrigel | 13 | Provider | WiCell Feeder Independent Pluripotent Stem Cell Protocol |